Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Compare efficacy: Three groups of antihistamine levocetrizine 10mg, bilastine 20mg and bepotastine 10mg in patients with urticaria for a period of two weeks.
Control Intervention1: Ant
Sponsors
Meenakshi medical college hospital and research institute
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with diagnosis of urticaria (acute/chronic) 2)Patients for whom documented consent has been obtained regarding their voluntary participation in this clinical study 3) Patients aged 18 years or older at the time that they provide consent. 4) Patient agrees not to take other treatments than those provided in the study.
Exclusion criteria
Exclusion criteria: 1)pregnant and lactating females 2)patients who are immunocompromised due to disease or drugs 3) Patients with pruritis caused due to other cutaneous skin disorders. 4) Patients with known hypersensitivity to antihistamines. 5) Known case of Bronchial asthama / COPD. 6) Patients with urticaria presenting with systemic signs/symptoms 7) Patients with urticaria and angio oedema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare efficacy of three group of antihistamineTimepoint: To compare efficacy of three group of antihistamine | — |
Secondary
| Measure | Time frame |
|---|---|
| To note down side effectsTimepoint: At baseline and after 2 weeks | — |
Countries
India
Contacts
Public ContactAishwarya krishnakumar
Meenakshi medical college hospital and research institute, Kanchipuram
Outcome results
None listed